These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20564150)

  • 101. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study.
    Park CH; Suh JH; Yoo HS; Lee JT; Kim DI
    Clin Nucl Med; 1986 Jul; 11(7):514-7. PubMed ID: 3015472
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
    Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
    J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals.
    Lambert B; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):980-9. PubMed ID: 16032439
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Effect of intrahepatic arterial infusion of 131I-labelled lipiodol on hepatocellular carcinoma of rat.
    Tsai C; Kusumoto Y; Harada R; Shima M; Nakata K; Kono K; Sato A; Ishii N; Koji T; Nagataki S
    Ann Acad Med Singap; 1986 Oct; 15(4):521-4. PubMed ID: 3032069
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Adjuvant Intrahepatic Injection Iodine-131-Lipiodol Improves Prognosis of Patients with Hepatocellular Carcinoma After Resection: a Meta-Analysis.
    Hong Y; Wu LP; Ye F; Zhou YM
    Indian J Surg; 2015 Dec; 77(Suppl 3):1227-32. PubMed ID: 27011542
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Elicitation of prior distributions for a phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma.
    Tan SB; Chung YF; Tai BC; Cheung YB; Machin D
    Control Clin Trials; 2003 Apr; 24(2):110-21. PubMed ID: 12689733
    [TBL] [Abstract][Full Text] [Related]  

  • 107. 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report.
    Sundram FX; Yu SW; Jeong JM; Somanesan S; Premaraj J; Saw MM; Tan BS
    Ann Acad Med Singap; 2001 Sep; 30(5):542-5. PubMed ID: 11603144
    [TBL] [Abstract][Full Text] [Related]  

  • 108. On developing a pragmatic strategy for clinical trials: A case study of hepatocellular carcinoma.
    Gandhi M; Tan SB; Chung Yaw Fui A; Machin D
    Contemp Clin Trials; 2015 Jul; 43():252-9. PubMed ID: 26111924
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Adjuvant Iodine (131) Lipiodol after Resection of Hepatocellular Carcinoma.
    Furtado RV; Ha L; Clarke S; Sandroussi C
    J Oncol; 2015; 2015():746917. PubMed ID: 26713092
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Bioavailability of oral vs intramuscular iodinated oil (Lipiodol UF) in healthy subjects.
    Leverge R; Bergmann JF; Simoneau G; Tillet Y; Bonnemain B
    J Endocrinol Invest; 2003; 26(2 Suppl):20-6. PubMed ID: 12762636
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma.
    Ng KM; Niu R; Yan TD; Zhao J; McKay E; Chu FC; Morris DL
    HPB (Oxford); 2008; 10(6):388-95. PubMed ID: 19088923
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Radiolabeled antibody therapy.
    Bucholtz JD
    Semin Oncol Nurs; 1987 Feb; 3(1):67-73. PubMed ID: 3031793
    [No Abstract]   [Full Text] [Related]  

  • 113. Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach.
    Oger E; Lavenu A; Bellissant E; Garin E; Polard E
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):956-63. PubMed ID: 21748824
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies - Experience in tertiary care oncology center in India.
    Bhargavi V; Subbanna I; Kallur KG; Patel A; Swamy S; Patil S
    South Asian J Cancer; 2019; 8(1):31-34. PubMed ID: 30766849
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The integration of tumor associated antigens in cancer management.
    Leibel SA; Klein JL; Sgagias M; Leichner P; Order SE
    Semin Oncol; 1981 Mar; 8(1):92-102. PubMed ID: 6264628
    [No Abstract]   [Full Text] [Related]  

  • 116. [Preliminary trial of palliative treatment of primary liver cancers with Au 198].
    Bresson Y; N'Doye R
    Bull Soc Med Afr Noire Lang Fr; 1972; 17(3):437-42. PubMed ID: 4123672
    [No Abstract]   [Full Text] [Related]  

  • 117. A new assay for lipiodol in a tumor using a combination of m-chloroperbenzoic acid-mediated oxidation and the iodo-starch reaction.
    Kozutsumi D; Ohshiba Y; Sugimoto T; Tsuboi H; Kawashima A; Kochiya M; Adachi M; Takami M
    Cancer Lett; 2000 Sep; 158(1):93-8. PubMed ID: 10940514
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Hepatic insufficiency and lipiodol].
    DUSSERT A
    J Med Bord; 1946 Jan; 123():24. PubMed ID: 21023998
    [No Abstract]   [Full Text] [Related]  

  • 119. Adjuvant
    Vogel A; Saborowski A
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):517-519. PubMed ID: 32164876
    [No Abstract]   [Full Text] [Related]  

  • 120. SBRT Using Residual Lipiodol as Surrogate Fiducial for Image Guidance in the Treatment of Recurrent or Residual Hepatocellular Carcinoma.
    Sioshansi S; Ding L; Fitzgerald TJ
    Pract Radiat Oncol; 2013; 3(2 Suppl 1):S17. PubMed ID: 24674498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.